Symbol="ARTL"
AssetType="Common Stock"
Name="Artelo Biosciences Inc"
Description="Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California."
CIK="1621221"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TRADE & SERVICES"
Industry="SERVICES-BUSINESS SERVICES, NEC"
Address="564 WEDGE LANE, FERNLEY, NV, US"
FiscalYearEnd="August"
LatestQuarter="2023-05-31"
MarketCapitalization="5654300"
EBITDA="-7440756"
PERatio="None"
PEGRatio="None"
BookValue="6.79"
DividendPerShare="0"
DividendYield="0"
EPS="-3.53"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.294"
ReturnOnEquityTTM="-0.474"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-3.53"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="22.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.395"
EVToRevenue="-"
EVToEBITDA="1.142"
Beta="0.915"
num_52WeekHigh="4.83"
num_52WeekLow="1.39"
num_50DayMovingAverage="1.982"
num_200DayMovingAverage="2.423"
SharesOutstanding="2855700"
DividendDate="2019-06-21"
ExDividendDate="None"
symbol="ARTL"
open="1.92"
high="1.97"
low="1.90"
price="1.96"
volume="4485.00"
latest_trading_day="2023-08-18"
previous_close="1.98"
change="-0.03"
change_percent="-1.2626%"
aroon_positive_momentum_days="19"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="19"
Volume_recent_avg="17612"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.28"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="19"
Aroon_momentum_negative="81"
image_negative_thumbnail_id_1="122"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0054.jpeg"
image_negative_thumbnail_id_2="515"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0090.jpeg"
image_neutral_thumbnail_id_1="594"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_neutral_thumbnail_id_2="561"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_positive_thumbnail_id_1="641"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0067.jpeg"
image_positive_thumbnail_id_2="704"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0004.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
